Sbi Securities Co., Ltd. Inmune Bio, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3 Trillion
- Q1 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 1,644 shares of INMB stock, worth $12,001. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,644
Previous 1,671
1.62%
Holding current value
$12,001
Previous $7.8 Million
64.53%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding INMB
# of Institutions
89Shares Held
6.93MCall Options Held
240KPut Options Held
74.6K-
Vanguard Group Inc Valley Forge, PA827KShares$6.03 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$5.93 Million0.0% of portfolio
-
Praetorian Pr LLC Rincon, PR812KShares$5.93 Million1.52% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$4.35 Million45.87% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL382KShares$2.79 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $131M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...